...
首页> 外文期刊>Vascular and endovascular surgery >The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery
【24h】

The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery

机译:膝上股pop开放旁路手术失败后使用内移植物进行腔内股pop旁路

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Redo femoropopliteal bypass surgery is associated with increased morbidity and related to a poorer outcome than primary procedures. Endografts might provide an alternative, avoiding dissection of a previously operated groin. Patients treated with a polytetrafluoroethylene-covered stents for superficial femoral artery occlusive disease between February 2009 and September 2011 were prospectively gathered. Demographics, clinical status, procedural aspects, and follow-up were retrieved. Seventy-four patients were included of which 5 (7%) were treated before with a femoropopliteal bypass. Indication for intervention was Rutherford category 3 in all patients and the median ankle-brachial index (ABI) was 0.68. Technical success was achieved in all cases. The postoperative course was uneventful in all and the ABI increased to 0.95. After a follow-up period of 18 months, 4 of 5 endografts remained patent. The use of endografts after failed femoropopliteal bypass surgery is feasible and safe and could be used to avoid or minimize a difficult and hazardous dissection of a previously operated area.
机译:重做股pop旁路手术与发病率增加有关,并且与主要手术相比效果差。内移植可能会提供另一种选择,避免解剖先前手术过的腹股沟。前瞻性地收集了2009年2月至2011年9月之间用聚四氟乙烯覆盖的支架治疗股浅动脉闭塞性疾病的患者。人口统计学,临床状况,程序方面和随访。包括74例患者,其中5例(7%)接受了股pop旁路治疗。所有患者的干预指征为Rutherford 3类,踝臂指数(ABI)为0.68。在所有情况下都取得了技术上的成功。术后过程总体平稳,ABI增至0.95。经过18个月的随访,在5个内移植物中,有4个仍处于专利保护状态。股pop旁路手术失败后使用内移植物是可行和安全的,并可用于避免或最大程度地减少先前手术区域的困难和危险解剖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号